The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...
Hosted on MSN
Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovid
Pharmaceutical giant Novavax on Monday announced that the U.S. Food and Drug Administration (FDA) approved its COVID-19 vaccine, Nuvaxovid. Novavax’s shares traded nearly 20% in pre-market trading at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results